EUCTR2013-002270-52-ES进行中（未招募）不适用
Effects of cinacalcet versus conventional treatment on metabolismbone and vascular involvement in advanced chronic renal failure
Hospital Universitari de Girona Dr.Josep Trueta0 个研究点开始时间: 2013年11月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patients of both sexes, aged greater than or equal to 18.
- •2. Adult patients suffering from chronic kidney failure (stadium V)and less than 1 year in sustitutive treatment
- •3.Patients with secondary hyperparathyroidism: iPTH> 150 pg / ml before inclusion in the study.
- •4.Patients in whom it has obtained written informed consent
- •for participation in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 40
排除标准
- •1. Patients younger than 18 years.
- •2. Patients who have been treated with cinacalcet 3 months prior to initiation of study.
- •3.Serum calcium levels less than 8.4 mg / dl at the time of inclusion
- •4.Functioning renal transplant patients
- •5.Gestation or pregnancy desire
- •6.Women of childbearing age, sexually active and who do not follow a contraception method acceptable to the researcher.
研究者
相似试验
已完成
不适用
Evaluation of cinacalcet on clinical outcome depending on serum PTH level in Japanese patients with SHPT:ECO studySecondary hyperparathyroidismJPRN-UMIN000002769Division of Kidney and Hypertension, Department of Internal Medicine,The Jikei University School of Medicine120
已完成
4 期
Efficacy and safety of treatment with Cinacalcet in patients with Primary Hyperparathyroidism due to a MEN-1 mutatioprimary hyperparathyroidismhyperactive parathyroid glands1008362410033949NL-OMON34871eids Universitair Medisch Centrum20
已完成
不适用
Prospective Study on the effects of cinacalcet HCL on vascular calcification and parathyroid glands size in patients on maintenance hemodialysischronic kidney disease patients with hyperparathyroidism undergoing hemodialysisJPRN-UMIN000002628Division of Nephrology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine60
招募中
不适用
Effectiviteit en veiligheid van behandeling met cinacalcet bij patiënten met primaire hyperparathyreoïdie door een MEN-I mutatie.MEN-1Primary HyperparathyroidismPrimair HyperparathyreoidieCinacalcetCaSRNL-OMON23587eiden University Medical CenterDutch MEN-1 Study Group30
进行中（未招募）
不适用
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismEUCTR2010-018861-53-NLeiden University Medical Center